StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.52−0.01 (-1.67%)

Close on Nov 17, 2026Market cap $14.24MP/E –Yield –

Earnings

Citius Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 12, 2027
Q1 FY2027 · estimated, before the open
Revenue, Q3 FY2026
$1.50M
EPS, Q3 FY2026
-$0.34
-$0.80 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Citius Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2027ended Dec 31, 2026Feb 12, 2027Expected––––
Q4 FY2026ended Sep 30, 2026Oct 26, 2026after the close–––Release
Q3 FY2026ended Jun 30, 2026Aug 14, 2026during market hours$1.50M–-$0.34Release
Q2 FY2026ended Mar 31, 2026May 15, 2026during market hours$1.70M–-$0.95Release
Q1 FY2026ended Dec 31, 2025Feb 13, 2026before the open–––Release
Q4 FY2025ended Sep 30, 2025Dec 23, 2025during market hours–––Release
Q3 FY2025ended Jun 30, 2025Aug 12, 2025during market hours––-$0.80Release
Q2 FY2025ended Mar 31, 2025May 14, 2025during market hours––-$1.27Release
Q4 FY2024ended Sep 30, 2024Dec 27, 2024during market hours–––Release
Q3 FY2024ended Jun 30, 2024Aug 12, 2024during market hours––-$0.06Release
Q2 FY2024ended Mar 31, 2024May 14, 2024during market hours––-$0.05Release
Q1 FY2024ended Dec 31, 2023Feb 15, 2024before the open––-$0.06Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Citius Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Citius Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Citius Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. Results
  3. Results
  4. News
  5. News
  6. Results
  7. News
  8. News
  9. News
  10. News
  11. News
  12. News
  13. Results
  14. Results
  15. Update

See a number that looks wrong?